Contribution of BCR-ABL kinase domain mutations to imatinib mesylate resistance in Philadelphia chromosome positive Malaysian chronic myeloid leukemia patients

QR Code

Contribution of BCR-ABL kinase domain mutations to imatinib mesylate resistance in Philadelphia chromosome positive Malaysian chronic myeloid leukemia patients

Development of resistance to imatinib mesylate (IM) in chronic myeloid leukemia (CML) patients is mediated by different mechanisms that can be classified as BCR-ABL dependent or BCR-ABL independent pathways. BCR-ABL dependent mechanisms are most frequently associated with point mutations in t...

Full description

Bibliographic Details
Main Authors:	Elias, Marjanu Hikmah, Baba, Abdul Aziz, Husin, Azlan, Abdullah, Abu Dzarr, Hassan, Rosline, Goh, Ai Sim, Abdul Wahid, S. Fadilah, Ankathil, Ravindran
Format:	Article
Language:	English
Published:	PAGEpress 2012
Subjects:	R5-920 Medicine (General)
Online Access:	http://eprints.usm.my/38527/ http://eprints.usm.my/38527/1/Contribution_of_BCR-ABL_kinase_domain_mutations_to_imatinib_mesylate_resistance_in_Philadelphia_chromosome.pdf

Similar Items

Molecular genetic and epigenetic mechanisms of primary and secondary resistance to imatinib mesylate treatment in ph chromosome positive chronic myeloid leukemia patients
by: Elias, Marjanu Hikmah
Published: (2015)

Detection of BCR-ABL T315i mutation in imatinib resistant chronic myeloid leukemia patients
by: Mardziah M,, et al.
Published: (2019)

Detection of PDGFRA mutations at exons 12 and 18 among chronic myeloid leukemia patients treated with imatinib mesylate
by: Razali, Ruzi Hamimi
Published: (2015)

Genetic determinants excluding GBCR::ABL mutations of imatinib mesylate therapy response among chronic myeloid leukaemia patients in Malaysia
by: Ismail, Siti Mariam
Published: (2023)

Imatinab mesylate treatment in Chronic Myeloid Leukemia (CML)- understanding the fundamental pharmacokinetic and pharmacogenetic mechanisms for variation in response
by: Ankathil, Ravindran
Published: (2016)

Molecular basis of primary and secondary resistance to imatinib mesylate
by: Abdul Aziz, Baba
Published: (2012)

Aleukemic bcr-abl positive granulocytic sarcoma
by: Kuan, Jew-Win, et al.
Published: (2009)

Influence of tert gene expression, telomerase activity and telomere length in relation to imatinib mesylate resistance in Malaysian chronic myeloid leukaemia patients
by: Shamshudin, Wati @ Hayati Mohd
Published: (2020)

Determination of gene copy number status in tert and terc among chronic myeloid leukaemia patients resist ant and responsive to imatinib mesylate treatment
by: Asrari, Zaidatul Shakila Mohamad
Published: (2014)

Application of high resolution melting (HRM) analysis in detection of PDGFRA gene mutations among chronic myeloid leukemia patients treated with imanitib mesylate
by: Rashid, Nur Sabrina Abd
Published: (2020)

Detection of BCR/ABL gene in chronic Myeloid Leukaemia: comparison of Fluorescence in situ Hybridisation (FISH), conventional Cytogenetics and Polymerase Chain Reaction (PCR) techniques
by: Reena RMZ,, et al.
Published: (2006)

Donor chimerism and bcr-abl gene status following non-myeloablative peripheral blood stem cell transplantation in chronic myeloid leukaemia patients in HUKM
by: Seman, Zainina, et al.
Published: (2008)

Disease acceptance and adherence to imatinib in Taiwanese chronic myeloid leukaemia outpatients
by: Chen, Li-Chia, et al.
Published: (2014)

C-kit Inhibition by Imatinib Mesylate Attenuates Progenitor Cell Expansion and Inhibits Liver Tumor Formation in Mice
by: Knight, B., et al.
Published: (2008)

Targeted RNAi of the mitogen-activated protein kinase pathway genes in acute myeloid leukemia cells
by: Mohd Hafiz, M.R., et al.
Published: (2013)

Influence of ORM1, PXR, CAR, CYP3A4 and CYP3A5 gene polymorphisms in mediating susceptibility risk to chronic myeloid leukaemia and response to imatinib mesylate therapy
by: Maddin, Najlaa
Published: (2017)

ABCB1 genetic variants in leukemias: current insights into treatment outcomes
by: Ankathil, Ravindran
Published: (2017)

ABCB1 genetic variants in leukemias: current insights into treatment outcomes
by: Ankathil, Ravindran
Published: (2017)

Ultra-high performance liquid chromatography (uhplc) method development and validation for the determination of serum imatinib and its active metabolite concentration among chronic myeloid leukemia patients
by: Liong, Tan Ka
Published: (2013)

Concomitant BCR-ABL and JAK2 V617F in a patient with myeloproliferative neoplasm: a case report
by: A, Alia Suzana, et al.
Published: (2023)

Imbalanced expression of polycistronic miRNA in acute myeloid leukemia
by: Kotaki, Ryutaro, et al.
Published: (2017)

Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia
by: Ley, T., et al.
Published: (2013)

Eccentricity of Acute Myeloid Leukemia with NPM1 and FLT3-ITD mutation: a case report
by: Nur Zainura Mohamad,, et al.
Published: (2022)

Clinical evaluation and proteomic profiles of acute myeloid leukemia patients, Saudi Arabia
by: Almaiman, Amer Abdulrahman
Published: (2015)

Gene aberrations and methylation analysis of JAK/stat and toll-like receptor downstream signalling in BCR-ABL-negative myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms overlap syndromes
by: Cai, Chia Yuh
Published: (2021)

Italian-American conversations on the mafia: Danilo Dolci visits Philadelphia’s 1961 Festival of Italy
by: Owen, Samantha
Published: (2017)

Proteomics profiling and genomics computational analysis of acute myeloid leukemia / Md. Mirazul Islam
by: Md. Mirazul, Islam
Published: (2017)

Concomitant t(8;21) and trisomy 4 in a patient with Acute Myeloid Leukemia (AML)
by: Phan CL,, et al.
Published: (2010)

Analysis of Madm, a novel adaptor protein that associates with Myeloid Leukemia Factor 1
by: Lim, Raelene
Published: (2003)

Inhibition of HOX/PBX dimer formation leads to necroptosis in acute myeloid leukemia cells
by: Alharbi, Raed A., et al.
Published: (2017)

Activity of the aurora kinase B inhibitor AZD1152 in acute myeloid leukaemia
by: Grundy, Martin
Published: (2012)

Deciphering S-Phase Protein Kinase 2 (Skp2) Mediated Regulation Of Telomerase Reverse Transcriptase (Tert) In Kasumi-1, T (8;21) Acute Myeloid Leukemia (Aml) Cell Line
by: Rosli, Nur Aliaa Arina
Published: (2023)

Molecular responses during chemotherapy in acute myeloid leukemias in predicting poor-response to standard chemotherapy.
by: Abdullah, Maha, et al.
Published: (2009)

Subtractive hybridization identifies stem cell-associated genes in an acute myeloid leukemia with poor prognosis
by: Ngiow, Shin Foong, et al.
Published: (2016)

Decitabine-Vorinostat combination treatment in acute myeloid leukemia activates pathways with potential for novel triple therapy
by: Young, Christine S., et al.
Published: (2017)

Cytotoxic Effects of Betulinic Acid and its Derivatives on Human Myeloid Leukemia (Hl-60) Cell Line
by: Faujan, Nur Hana
Published: (2008)

A randomized control trial comparing peginterferon-α-2a versus observation after stopping tyrosine kinase inhibitor in chronic myeloid leukemia with deep molecular response for at least two years
by: Kuan, Jew-Win, et al.
Published: (2016)

Antitumor Effects of Madu Lebah Tualang on Human Leukemia Cell Line (K562)
by: Hassan, Rosline
Published: (2016)

Antileukemic Effect of Tualang Honey on Acute and Chronic Leukemia Cell Lines
by: Nik Man, Nik Muhd Khuzaimi, et al.
Published: (2015)

Exploration Of Real Time PCR As A New Diagnostic Method Of Fragile X Syndrome
by: Elias, Marjanu Hikmah
Published: (2010)